Literature DB >> 8975633

Population toxicokinetics of tetrachloroethylene.

F Y Bois1, A Gelman, J Jiang, D R Maszle, L Zeise, G Alexeef.   

Abstract

In assessing the distribution and metabolism of toxic compounds in the body, measurements are not always feasible for ethical or technical reasons. Computer modeling offers a reasonable alternative, but the variability and complexity of biological systems pose unique challenges in model building and adjustment. Recent tools from population pharmacokinetics, Bayesian statistical inference, and physiological modeling can be brought together to solve these problems. As an example, we modeled the distribution and metabolism of tetrachloroethylene (PERC) in humans. We derive statistical distributions for the parameters of a physiological model of PERC, on the basis of data from Monster et al. (1979). The model adequately fits both prior physiological information and experimental data. An estimate of the relationship between PERC exposure and fraction metabolized is obtained. Our median population estimate for the fraction of inhaled tetrachloroethylene that is metabolized, at exposure levels exceeding current occupational standards, is 1.5% [95% confidence interval (0.52%, 4.1%)]. At levels approaching ambient inhalation exposure (0.001 ppm), the median estimate of the fraction metabolized is much higher, at 36% [95% confidence interval (15%, 58%)]. This disproportionality should be taken into account when deriving safe exposure limits for tetrachloroethylene and deserves to be verified by further experiments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8975633     DOI: 10.1007/s002040050284

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  A physiologically based pharmacokinetic model for capreomycin.

Authors:  B Reisfeld; C P Metzler; M A Lyons; A N Mayeno; E J Brooks; M A Degroote
Journal:  Antimicrob Agents Chemother       Date:  2011-12-05       Impact factor: 5.191

2.  Impact of Nonalcoholic Fatty Liver Disease on Toxicokinetics of Tetrachloroethylene in Mice.

Authors:  Joseph A Cichocki; Shinji Furuya; Kranti Konganti; Yu-Syuan Luo; Thomas J McDonald; Yasuhiro Iwata; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  J Pharmacol Exp Ther       Date:  2017-02-01       Impact factor: 4.030

3.  Incorporation of the glutathione conjugation pathway in an updated physiologically-based pharmacokinetic model for perchloroethylene in mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Appl Pharmacol       Date:  2018-05-29       Impact factor: 4.219

4.  Toxicity testing in the 21st century: a vision and a strategy.

Authors:  Daniel Krewski; Daniel Acosta; Melvin Andersen; Henry Anderson; John C Bailar; Kim Boekelheide; Robert Brent; Gail Charnley; Vivian G Cheung; Sidney Green; Karl T Kelsey; Nancy I Kerkvliet; Abby A Li; Lawrence McCray; Otto Meyer; Reid D Patterson; William Pennie; Robert A Scala; Gina M Solomon; Martin Stephens; James Yager; Lauren Zeise
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2010-02       Impact factor: 6.393

5.  Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis.

Authors:  John F Wambaugh; Hugh A Barton; R Woodrow Setzer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-01-08       Impact factor: 2.745

6.  A Bayesian population PBPK model for multiroute chloroform exposure.

Authors:  Yuching Yang; Xu Xu; Panos G Georgopoulos
Journal:  J Expo Sci Environ Epidemiol       Date:  2009-05-27       Impact factor: 5.563

7.  Quantitative Characterization of Population-Wide Tissue- and Metabolite-Specific Variability in Perchloroethylene Toxicokinetics in Male Mice.

Authors:  Chimeddulam Dalaijamts; Joseph A Cichocki; Yu-Syuan Luo; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Sci       Date:  2021-08-03       Impact factor: 4.849

8.  A computational model of the hypothalamic: pituitary: gonadal axis in female fathead minnows (Pimephales promelas) exposed to 17α-ethynylestradiol and 17β-trenbolone.

Authors:  Zhenhong Li; Kevin J Kroll; Kathleen M Jensen; Daniel L Villeneuve; Gerald T Ankley; Jayne V Brian; María S Sepúlveda; Edward F Orlando; James M Lazorchak; Mitchell Kostich; Brandon Armstrong; Nancy D Denslow; Karen H Watanabe
Journal:  BMC Syst Biol       Date:  2011-05-05

9.  Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.

Authors:  Thierry Wendling; Swati Dumitras; Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-01       Impact factor: 2.745

10.  Addressing human variability in next-generation human health risk assessments of environmental chemicals.

Authors:  Lauren Zeise; Frederic Y Bois; Weihsueh A Chiu; Dale Hattis; Ivan Rusyn; Kathryn Z Guyton
Journal:  Environ Health Perspect       Date:  2012-10-19       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.